A Food and Drug Administration advisory committee votes 5-4 not to widen sales of silicone breast implants manufactured by Inamed. Some studies show the implants increase risk of cognitive difficulties and fatigue. Use of the silicone implants has been tightly restricted since 1992. The panel considers a second manufacturer Wednesday.
NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.